# A Phase I Clinical Trial of Recombinant Herpes Zoster Vaccine (CHO Cell)

> **NCT07633197** · PHASE1 · ENROLLING_BY_INVITATION · sponsor: **Changchun BCHT Biotechnology Co.** · enrollment: 120 (estimated)

## Conditions studied

- Herpes

## Interventions

- **BIOLOGICAL:** Recombinant Herpes Zoster Vaccine
- **BIOLOGICAL:** adjuvant placebo
- **BIOLOGICAL:** Placebo

## Key facts

- **NCT ID:** NCT07633197
- **Lead sponsor:** Changchun BCHT Biotechnology Co.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** ENROLLING_BY_INVITATION
- **Start date:** 2026-05-28
- **Primary completion:** 2026-12-28
- **Final completion:** 2027-11-30
- **Target enrollment:** 120 (ESTIMATED)
- **Last updated:** 2026-06-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07633197

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07633197, "A Phase I Clinical Trial of Recombinant Herpes Zoster Vaccine (CHO Cell)". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07633197. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*